中(zhong)源協和公(gong)(gong)告,公(gong)(gong)司(si)擬同意(yi)子(zi)公(gong)(gong)司(si)北京傲銳(rui)東源生物科(ke)技有限公(gong)(gong)司(si)以不(bu)超過4721萬元的(de)價格參與(yu)摘(zhai)(zhai)牌受(shou)讓金(jin)源投資持(chi)(chi)有的(de)無錫(xi)傲銳(rui)17.24%股權,以不(bu)超過1890萬元的(de)價格參與(yu)摘(zhai)(zhai)牌受(shou)讓馬山生物持(chi)(chi)有的(de)無錫(xi)傲銳(rui)6.9%股權,合(he)計不(bu)超過6611萬元,并辦(ban)理相關手續。摘(zhai)(zhai)牌受(shou)讓成功后,北京傲銳(rui)將持(chi)(chi)有無錫(xi)傲銳(rui)100%的(de)股權。